Screening for Anxiety and Depression in people with psoriasis: a cross sectional study in a tertiary referral setting:A cross-sectional study in a tertiary referral setting

Autor: Lamb, R.C., Matcham, Faith, Turner, M, Rayner, L, Simpson, A, Hotopf, M, Barker, J.N.W.N., Jackson, K, Smith, C.H.
Jazyk: angličtina
Rok vydání: 2016
Zdroj: Lamb, R C, Matcham, F, Turner, M, Rayner, L, Simpson, A, Hotopf, M, Barker, J N W N, Jackson, K & Smith, C H 2016, ' Screening for Anxiety and Depression in people with psoriasis: a cross sectional study in a tertiary referral setting : A cross-sectional study in a tertiary referral setting ', British Journal of Dermatology . https://doi.org/10.1111/bjd.14833
DOI: 10.1111/bjd.14833
Popis: BACKGROUND National Institute for Health and Care Excellence (NICE) guidance recommends assessment of psychological and social well-being in people with psoriasis. OBJECTIVES To systematically screen for depression and anxiety in patients with psoriasis in routine clinical practice and identify at-risk groups for psychiatric morbidity. METHODS Consecutive patients attending a single, tertiary centre over a 10-month period were invited to complete Patient Health Questionnaire Depression Scale (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7) and Dermatology Life Quality Index (DLQI) as part of the IMPARTS: Integrating Mental and Physical healthcare; Research, Training and Services. Information on demographics, treatment and clinical disease severity were collated from EPR. Regression models were used to identify at-risk groups for psychiatric morbidity. RESULTS Of 607 patients (56.2% on biologics) included, 9.9% (95%CI: 7.5-12.3%) screened positive for major depressive disorder and 13.1% (95%CI: 10.4-15.8%) for generalised anxiety disorder ([GAD] GAD-7 >9). Suicidal ideation was reported in 35% of MDD; DLQI was
Databáze: OpenAIRE